By Matt Skoufalos
Camille Farhat will be the new CEO of RTI Surgical Inc. of Alachua, Florida, effective March 15, 2017. Farhat succeeds interim CEO Robert P. Jordheim, who will resume his role as the company’s CFO. Farhat is the past president and CEO of American Medical Systems (AMS), and helped drive the growth of that company’s men’s and prostate health businesses, which were later acquired by Boston Scientific for $1.65 billion. Farhat has also held senior leadership roles with Baxter Healthcare, Medtronic Inc., and General Electric.
ZDi Solutions of Knoxville, Tennessee has named Justin Sims its new EVP of Sales. Sims most recently was SVP of DirecTV’s commercial division, has consulted for AT&T, Comcast, Best Buy, and Dish, and is a three-overseas-tours U.S. Army veteran. Sims will work to build relationships among ZDi clinical, physician, and staff customers.
Amid the spin-off of its imaging components business into Varex Imaging Corporation, Varian of Palo Alto, California has also made changes to its senior leadership. Magnus Momsen will replace Clarence Verhoes as Varian’s SVP and corporate controller; Verhoef will in turn become the Varex Imaging CFO. Ruediger Naumann-Etienne and Eric R. Reinhardt are leaving the Varian board of directors to join the board of Varex Imaging, and Varian has reduced the size of its board to eight members.
NxStage Medical of Lawrence, Massachusetts, has named nephrologist Allan Collins, M.D., FACP, its CMO. Collins will continue to chair the company’s scientific advisory board as well as leading its medical affairs team. Collins teaches medicine at the University of Minnesota and directs the interdisciplinary Chronic Research Disease Group, a biomedical public-health chronic illness research group. He also coordinated the United States Renal Data System annual data report from 2000 to 2014, and was President of the National Kidney Foundation from 2006 through 2008.
Larry Schlesinger has been named President and CEO of the San Antonio, Texas-based Texas Biomedical Research Institute, effective May 31, 2017. Schlesinger chairs the Ohio State University Department of Microbial Infection and Immunity and directs its Center for Microbial Interface Biology. Schlesinger’s studies have translated into drug discovery platforms, and he will continue his research at Texas Biomed. He is a member of the NIH National Institute of Allergy and Infectious Diseases Council, a Fellow of the American Association for the Advancement of Science, and a member of the Association of American Physicians and American Academy of Microbiology. Schlesinger has a bachelor’s degree in biology from Cornell University and a medical degree from Rutgers Medical School.
TSO3 Inc. of Quebec City, Quebec, Canada, has named Mark Pasmore its VP of Research and Development. Pasmore has held leadership positions with Baxter Healthcare and STERIS and was an assistant research professor in the Department of Chemical and Biological Engineering at Montana State University. He has a doctorate in chemical engineering from the University of Colorado, and publishes research on biofilm.
xG Health Solutions of Columbia, Maryland has named Jess Cramer its VP of Care Management. Cramer joined the company from VillageMD, where she led care management and physician operations. She has also worked in clinical programs for Evolent Health and Anthem BCBS, and holds a BSN from the University of Rochester, a degree she used in an earlier career as a bone-marrow transplant nurse.
Lynn Dolce, MFT has been named CEO of the 165-year-old Edgewood Center for Children and Families in San Francisco, California. Dolce succeeds acting Interim CEO Nancy Rubin. She was most recently the Foster Care Mental Health Director at the San Francisco Department of Public Health, has previously managed pediatric mental health services for children with the University of California, San Francisco (UCSF), and San Francisco General Hospital Pediatrics.
Click here if you have a person on the move you would like to share with us.